
Peter Lucas
Professor of Laboratory Medicine and Pathology · Mayo Clinic College of Medicine and Science
Credentials: · · · ·
History
1998–1999
1996–1998
- 1992–1994
- 1983–1987
Research
Inhibition of adipogenesis by Wnt signaling
Science · 2000 · 1,580 citations
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
New England Journal of Medicine · 2021 · 1,347 citations
An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways
Journal of Biological Chemistry · 2000 · 445 citations

34 papers

19 papers
- AB
12 papers
- EM
10 papers

10 papers · 6 as a resident

10 papers
- SS
9 papers
- CA
8 papers
Grants
- 2023–2028
Role of MALT1 in Regulating the Breast Cancer Immune Microenvironment
National Cancer Institute · R01
Contact PI · $1.6M · Mayo Clinic Rochester
- 2005–2027
Mayo Clinic Breast Cancer SPORE
National Cancer Institute · P50
Project lead · $1.3M · Mayo Clinic Rochester
- 2015–2026
National Cancer Institute · U24
PI · $22M · Nrg Oncology Foundation, Inc.
- 2018–2024
New Mechanisms for Modulating the MALT1 Oncoprotein
National Cancer Institute · R01
PI · $2.2M · University of Pittsburgh at Pittsburgh




